EUVIMEDEUVIMED entdecken
Open Access

In vivo membrane engineering traps Gd-based MRI contrast agents for detecting microhepatocellular carcinoma

Chunping Mao iD, Jie Yi iD, Fuan Deng iD, Wanning Zhu iD, Jiaru Zhao, Hualing Li, Luoxing Xia iD, Jianing Ji, Yuxiang Xiong, Jiayao Cai, Lingdong Jiang, Jun Shen iD und 2 weitere

Science Advances · 2026

DOI: 10.1126/sciadv.aec9913 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, 2026. Verfasst von Chunping Mao und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, China. Hauptthemen laut MEDLINE: Contrast Media, Magnetic Resonance Imaging, Liver Neoplasms, Carcinoma, Hepatocellular. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China, China Postdoctoral Science Foundation, Basic and Applied Basic Research Foundation of Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Accurate detection of microhepatocellular carcinoma (HCC) remains a major clinical challenge owing to the limited specificity and sensitivity of current imaging modalities. Herein, we present a dual-injection magnetic resonance imaging (MRI) peptidic probe based on in vivo membrane engineering, achieving in situ signal amplification and molecularly precise imaging. The first injection of programmable nanoparticles coassembled from two peptide monomers, incorporating a GPC3-targeting ligand, a β sheet–forming motif, a dibenzocyclooctyne (DBCO) handle, and porphyrin IX (PpIX) for fluorescence tracking. Following systemic administration, the nanoparticles high-specifically bind to GPC3-overexpressing tumor membranes and transform into surface-anchored nanofibrils, exposing confined DBCO groups. A second injection of azide-modified Gd-DOTA enables rapid copper-free click conjugation on the nanofibrillar scaffold, yielding a nearly fourfold increase in longitudinal relaxivity. MRI demonstrated strong T 1 -weighted signal enhancement and high tumor-to-liver contrast in Hepa1-6 tumor-bearing mice. In vivo membrane engineering strategy establishes a generalizable platform for receptor-guided molecular imaging and early cancer detection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Contrast MediaMagnetic Resonance ImagingLiver NeoplasmsCarcinoma, HepatocellularGadoliniumAnimalsMiceHumansNanoparticlesCell Line, Tumor

Substanzen

Contrast MediaGadolinium

Autor:innen und Institutionen

  • Department of Radiology, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, China.
  • Guangdong Provincial Key Laboratory of Advanced Biomaterials, Department of Biomedical Engineering, Southern University of Science and Technology, Shenzhen 518055, China.
  • Department of Gastroenterology, Jingmen Central Hospital, Jingmen 448000, China.
  • Department of Radiology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou 510120, China.

ORCID-Profile: Chunping Mao, Jie Yi, Fuan Deng, Wanning Zhu, Luoxing Xia, Jun Shen, Guobin Hong, Lu Zhang

Förderung

  • National Natural Science Foundation of China
  • China Postdoctoral Science Foundation
  • Basic and Applied Basic Research Foundation of Guangdong Province
  • National key R&D program of China
  • Shenzhen Science and Technology Innovation Committee
  • Guangdong Provincial Key Laboratory of Advanced Biomaterials
  • Shenzhen Medical Research Fund
  • Starting Grant from Southern University of Science and Technology

Zitieren

APA

Mao, C., Yi, J., Deng, F., Zhu, W., Zhao, J., Li, H., Xia, L., Ji, J., Xiong, Y., Cai, J., Jiang, L., Shen, J., Hong, G., & Zhang, L. (2026). In vivo membrane engineering traps Gd-based MRI contrast agents for detecting microhepatocellular carcinoma. Science Advances. https://doi.org/10.1126/sciadv.aec9913

Vancouver

Mao C, Yi J, Deng F, Zhu W, Zhao J, Li H, et al. In vivo membrane engineering traps Gd-based MRI contrast agents for detecting microhepatocellular carcinoma. Science Advances. 2026. doi:10.1126/sciadv.aec9913

BibTeX
@article{Mao2026,
  author = {Mao, Chunping and Yi, Jie and Deng, Fuan and Zhu, Wanning and Zhao, Jiaru and Li, Hualing and Xia, Luoxing and Ji, Jianing and Xiong, Yuxiang and Cai, Jiayao and Jiang, Lingdong and Shen, Jun and Hong, Guobin and Zhang, Lu},
  title = {In vivo membrane engineering traps Gd-based MRI contrast agents for detecting microhepatocellular carcinoma},
  journal = {Science Advances},
  year = {2026},
  doi = {10.1126/sciadv.aec9913}
}
Kostenlos starten →